Perspectives in Drug Discovery and Design

5.9k citations
212 papers · indexed · active since 1950

Perspectives in Drug Discovery and Design

193 papers receiving 5.2k citations

Peers

Perspectives in Drug Discovery and Design
Comparison fields: 5 of 177
  • Computational Theory and Mathematics 2.1k
  • Virology 428
  • Molecular Biology 3.2k
  • Organic Chemistry 1.3k
  • Spectroscopy 658
Replace Progress in medicinal chemistry with:
Progress in medicinal chemistry United Kingdom
Annual Review of Biophysics United States
Critical Reviews in Therapeutic Drug Carrier Systems India
Current Protocols in Bioinformatics United States
WIREs Systems Biology and Medicine United States
Methods of biochemical analysis United States
Molecular Interventions United States
Journal of Structural and Functional Genomics United States
Annual Review of Chemical and Biomolecular Engineering United States
International Journal of Cell Biology United States
Perspectives in Drug Discovery and Design relative to Progress in medicinal chemistry United Kingdom Progress in medicinal chemistry's profile →
Citations per field
00.5×2.7×
Progress in medicinal chemistry · 1×
Citations per year

Countries where authors publish in Perspectives in Drug Discovery and Design

Since Specialization
Citations

This map shows the geographic impact of research published in Perspectives in Drug Discovery and Design. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Perspectives in Drug Discovery and Design with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perspectives in Drug Discovery and Design more than expected).

Fields of papers published in Perspectives in Drug Discovery and Design

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Perspectives in Drug Discovery and Design. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Perspectives in Drug Discovery and Design.

About Perspectives in Drug Discovery and Design

The 212 papers published in Perspectives in Drug Discovery and Design in the last decades have received a total of 5.9k indexed citations . Papers published in Perspectives in Drug Discovery and Design usually cover Virology (32 papers), Computational Theory and Mathematics (65 papers), Molecular Biology (107 papers), Spectroscopy (25 papers) and Hematology (13 papers) specifically the topics of Computational Drug Discovery Methods (65 papers), HIV Research and Treatment (32 papers), Protein Structure and Dynamics (25 papers), Analytical Chemistry and Chromatography (18 papers), Chemical Synthesis and Analysis (18 papers), HIV/AIDS drug development and treatment (17 papers), Ion channel regulation and function (16 papers) and Peptidase Inhibition and Analysis (15 papers). The most active scholars publishing in Perspectives in Drug Discovery and Design are Peter A. Kollman, Irina Massova, Richard D. Cramer, Krzysztof Appelt, Ingo Muegge, John Wu, Peter W. Sprague, Christian Laurence, M. Berthelot and Hugo Kubinyi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026